Inactive Instrument
Guided Therapeutics Inc Stock OTC Bulletin Board
Stocks
US40171F2048
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-14 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 28M 24.25M 22.6M 20.79M 39.25M 2.66B 39.68M 266M 104M 1.33B 105M 103M 4.41B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 30.87M 26.74M 24.92M 22.92M 43.28M 2.94B 43.76M 293M 115M 1.47B 116M 113M 4.86B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.32% | +0.25% | +23.85% | +5.32% | 209B | ||
| +2.51% | +0.31% | +1.11% | -21.63% | 137B | ||
| +1.88% | +3.70% | -22.38% | +21.30% | 130B | ||
| -2.75% | +3.65% | -55.30% | -5.88% | 71.14B | ||
| -0.70% | +6.32% | +11.09% | +11.84% | 51.59B | ||
| +0.62% | +9.24% | -15.14% | -20.39% | 49.99B | ||
| +1.37% | +0.41% | +22.88% | +11.73% | 39.31B | ||
| +0.99% | +4.19% | +40.06% | +37.98% | 38.89B | ||
| +0.40% | +7.21% | -23.13% | +24.98% | 32.19B | ||
| Average | +0.68% | +3.19% | -1.88% | +7.25% | 84.33B | |
| Weighted average by Cap. | +1.13% | +1.42% | -0.24% | +3.74% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.06K 5.65K 5.2K 9.81K 666K 9.92K 66.41K 26.07K 333K 26.29K 25.71K 1.1M | 767K 664K 619K 570K 1.08M 72.93M 1.09M 7.28M 2.86M 36.49M 2.88M 2.82M 121M |
| Net income | -2.42M -2.09M -1.95M -1.79M -3.39M -230M -3.43M -22.93M -9M -115M -9.08M -8.88M -381M | -3.2M -2.77M -2.58M -2.37M -4.48M -304M -4.53M -30.32M -11.9M -152M -12M -11.74M -504M |
| Net Debt | 1.77M 1.53M 1.43M 1.32M 2.48M 168M 2.51M 16.8M 6.59M 84.26M 6.65M 6.5M 279M | 2.88M 2.49M 2.32M 2.14M 4.03M 273M 4.08M 27.29M 10.71M 137M 10.8M 10.56M 453M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















